Wm Technology Stock Earnings Reports

WM Technologies reported Q1 2026 revenue of $43.6 million (down 2% YoY, up 1% sequentially), in line with expectations. Average monthly paying clients were ~4,983 (down 4% YoY) and average revenue per paying client was $2,914. Operating expenses were $43.4 million, driven higher by a $3.9 million allowance for doubtful accounts; adjusted EBITDA was $5.9 million and net income was $1.7 million. Net cash used in operations was $1.3 million for the quarter and cash and investments totaled $57 million. Management highlighted ongoing industry headwinds — price compression, elevated taxes, constrained consumer spend, limited capital access and regulatory uncertainty — which continue to pressure client budgets and drive churn, particularly in mature markets (California, Michigan, Colorado). Key strategic developments: (1) the DOJ rescheduling of FDA‑approved medical cannabis products to Schedule III is viewed as constructive but not expected to materially change near‑term operations; and (2) the company’s voluntary delisting from Nasdaq is intentional, aimed at providing greater flexibility to invest the balance sheet into strategic clients/partners and to expand technology and services into areas previously restricted by exchange policies. Guidance: management expects Q2 revenue to decline sequentially by low single digits, reflecting continued churn in mature markets and normalization after 4/20 seasonality. Management priorities remain disciplined cost control, selective investment in product and marketplace expansion, and supporting clients while positioning for longer‑term industry improvements.